Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNA-Targeted Gene Therapies for Neurodegenerative, Neuromuscular and Retinal Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/34uN6SX
via IFTTT